|Grant Affiliation:||Gallo: Systemic, Mucosal & Passive Immunity|
|Strategy:||Prophylactic neutralizing Ab|
|Study Type:||Antibody Screening|
|Study Start Date:||2009-03-10|
|Study Made Public:||2012-07-16|
Isolation of anti-Env monoclonal antibodies from HIV-1 controllers.
CAVD 347 is an immunogenicity study of novel neutralizing monoclonal human anti-HIV-1 envelope monoclonal antibodies isolated from HIV-1 controllers.
Sign in to see full information about this study and to download study data.
ProductsNo Products used in study
No integrated data is available for this study.
No non-integrated data is available for this study.